Previously Known As : Sbi Pharma Fund
Sbi Healthcare Opportunities Fund Datagrid
Category Pharma Fund
BMSMONEY Rank -
Rating
Growth Option 30-04-2026
NAV ₹439.26(R) +0.23% ₹507.01(D) +0.23%
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular 4.56% 24.91% 15.57% 20.11% 12.3%
Direct 5.63% 26.22% 16.8% 21.39% 13.54%
Nifty Pharma TRI 7.64% 23.53% 12.38% 14.7% 8.26%
SIP (XIRR) Regular 6.27% 14.42% 17.3% 19.67% 16.85%
Direct 7.34% 15.66% 18.55% 20.99% 18.06%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
1.2 0.63 1.09 4.2% -0.46
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
14.75% -15.67% -12.33% 0.81 10.7%
Fund AUM As on: 30/12/2025 4058 Cr
Top Pharma Fund
Fund Name Rank Rating
Mirae Asset Healthcare Fund -
Aditya Birla Sun Life Pharma & Healthcare Fund -
Uti Healthcare Fund -
Sbi Healthcare Opportunities Fund -
Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund -
Nippon India Pharma Fund -
Tata India Pharma & Healthcare Fund -

NAV Date: 30-04-2026

Scheme Name NAV Rupee Change Percent Change
SBI Healthcare Opportunities Fund - Regular Plan - Income Distribution cum Capital Withdrawal Option (IDCW) 276.71
0.6200
0.2300%
SBI Healthcare Opportunities Fund - Direct Plan - Income Distribution cum Capital Withdrawal Option (IDCW) 352.26
0.8000
0.2300%
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH 439.26
0.9900
0.2300%
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH 507.01
1.1600
0.2300%

Review Date: 30-04-2026

Beginning of Analysis

The Sbi Healthcare Opportunities Fund has shown an excellent past performence in Pharma Fund. The Sbi Healthcare Opportunities Fund has a Jensen Alpha of 4.2% which is higher than the category average of 0.91%. Here the Sbi Healthcare Opportunities Fund has shown very good performance in terms of risk adjusted returns. The Sbi Healthcare Opportunities Fund has a Sharpe Ratio of 1.2 which is higher than the category average of 1.01. Here the Sbi Healthcare Opportunities Fund has shown very good performance in terms of risk adjusted returns.
The past performance of the {fund_name_eng} may or may not be sustained in the future. The review is not investment advice nor is it a recommendation to buy or sell funds.
Pharma Mutual Funds

Sbi Healthcare Opportunities Fund Return Analysis

The Sbi Healthcare Opportunities Fund has delivered a mixed performance across various time horizons, showcasing both strengths and challenges when compared to its Pharma Fund peers and the Nifty Pharma TRI benchmark. This analysis examines the fund’s returns over periods ranging from one month to ten years, alongside its Systematic Investment Plan (SIP) performance, highlighting its rankings within the Pharma Fund category and its ability to outperform or underperform the benchmark and category averages.

  • The fund has given a return of 5.8%, 8.48 and 0.96 in last one, three and six months respectively. In the same period the category average return was 6.93%, 7.81% and 0.9% respectively.
  • Sbi Healthcare Opportunities Fund has given a return of 5.63% in last one year. In the same period the Nifty Pharma TRI return was 7.64%. The fund has given 2.01% less return than the benchmark return.
  • The fund has given a return of 26.22% in last three years and rank 2nd out of eight funds in the category. In the same period the Nifty Pharma TRI return was 23.53%. The fund has given 2.69% more return than the benchmark return.
  • Sbi Healthcare Opportunities Fund has given a return of 16.8% in last five years and category average returns is 15.53% in same period. The fund ranked 2.0nd out of eight funds in the category. In the same period the Nifty Pharma TRI return was 12.38%. The fund has given 4.42% more return than the benchmark return.
  • The fund has given a return of 13.54% in last ten years and ranked 4.0th out of four funds in the category. In the same period the Nifty Pharma TRI return was 8.26%. The fund has given 5.28% more return than the benchmark return.
  • The fund has given a SIP return of 7.34% in last one year whereas category average SIP return is 6.91%. The fund one year return rank in the category is 9th in 15 funds
  • The fund has SIP return of 15.66% in last three years and ranks 4th in 8 funds. Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund has given the highest SIP return (16.84%) in the category in last three years.
  • The fund has SIP return of 18.55% in last five years whereas category average SIP return is 16.9%.

Sbi Healthcare Opportunities Fund Risk Analysis

  • The fund has a standard deviation of 14.75 and semi deviation of 10.7. The category average standard deviation is 15.97 and semi deviation is 11.32.
  • The fund has a Value at Risk (VaR) of -15.67 and a maximum drawdown of -12.33. The category average VaR is -19.09 and the maximum drawdown is -14.79. The fund has a beta of 0.77 which shows that fund is less volatile than the benchmark.

Standard deviation measures the fund's return volatility and Semi deviation focuses on downside volatility. Value at Risk (VaR) is a measure of the risk of investments. Maximum Drawdown is the maximum loss from a peak to a trough of a portfolio. Beta measures the volatility of the fund compared to the benchmark. A beta of 1 indicates that the fund will move in line with the benchmark. A beta of more than 1 indicates that the fund will be more volatile than the benchmark and vice versa.


  • Very Good Performance in Pharma Fund Category
  • Good Performance in Pharma Fund Category
  • Poor Performance in Pharma Fund Category
  • Very Poor Performance in Pharma Fund Category

    • Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.

    Data Source: www.amfiindia.com

    SEBI Categorization


    KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
    1M Return % 5.71 4.66
    6.81
    		3.75 | 9.18 13 | 16 Poor
    3M Return % 8.21 7.39
    7.45
    		4.25 | 10.64 6 | 16 Good
    6M Return % 0.45 4.60
    0.22
    		-3.15 | 4.92 7 | 16 Good
    1Y Return % 4.56 7.64
    6.79
    		2.30 | 13.84 13 | 15 Poor
    3Y Return % 24.91 23.53
    23.72
    		21.84 | 27.10 3 | 8 Good
    5Y Return % 15.57 12.38
    14.15
    		12.58 | 16.24 2 | 8 Very Good
    7Y Return % 20.11 14.70
    19.92
    		18.37 | 21.48 4 | 7 Good
    10Y Return % 12.30 8.26
    12.90
    		12.14 | 14.46 3 | 4 Average
    15Y Return % 16.38 11.99
    15.48
    		14.07 | 16.38 1 | 3 Very Good
    1Y SIP Return % 6.27
    5.50
    		-12.62 | 14.28 7 | 15 Good
    3Y SIP Return % 14.42
    12.93
    		9.00 | 15.83 4 | 8 Good
    5Y SIP Return % 17.30
    15.51
    		13.66 | 18.25 2 | 8 Very Good
    7Y SIP Return % 19.67
    18.50
    		16.84 | 20.55 2 | 7 Very Good
    10Y SIP Return % 16.85
    16.30
    		15.58 | 16.85 1 | 4 Very Good
    15Y SIP Return % 15.64
    15.39
    		14.51 | 16.01 2 | 3 Good
    Standard Deviation 14.75
    15.97
    		14.75 | 16.83 1 | 8 Very Good
    Semi Deviation 10.70
    11.32
    		10.52 | 12.07 2 | 8 Very Good
    Max Drawdown % -12.33
    -14.79
    		-16.36 | -12.33 1 | 8 Very Good
    VaR 1 Y % -15.67
    -19.09
    		-23.30 | -15.67 1 | 8 Very Good
    Average Drawdown % -5.39
    -5.48
    		-6.79 | -3.72 4 | 8 Good
    Sharpe Ratio 1.20
    1.01
    		0.85 | 1.20 1 | 8 Very Good
    Sterling Ratio 1.09
    0.92
    		0.79 | 1.09 1 | 8 Very Good
    Sortino Ratio 0.63
    0.53
    		0.43 | 0.63 1 | 8 Very Good
    Jensen Alpha % 4.20
    0.91
    		-2.04 | 4.20 1 | 8 Very Good
    Treynor Ratio -0.46
    -0.43
    		-0.48 | -0.40 7 | 8 Poor
    Modigliani Square Measure % 27.07
    23.67
    		20.89 | 27.07 1 | 8 Very Good
    Alpha % -1.04
    -1.43
    		-3.34 | 1.08 3 | 8 Good
    Return data last Updated On : April 30, 2026.
    Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : March 30, 2026
    KPIs: Key Performance Indicators

    Rotate the phone! Best viewed in landscape mode on mobile.
    KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
    1M Return % 5.80 4.66 6.93 3.90 | 9.25 13 | 16 Poor
    3M Return % 8.48 7.39 7.81 4.69 | 11.05 6 | 16 Good
    6M Return % 0.96 4.60 0.90 -2.46 | 5.52 8 | 16 Good
    1Y Return % 5.63 7.64 8.22 3.81 | 15.19 13 | 15 Poor
    3Y Return % 26.22 23.53 25.18 23.27 | 28.19 2 | 8 Very Good
    5Y Return % 16.80 12.38 15.53 14.18 | 17.27 2 | 8 Very Good
    7Y Return % 21.39 14.70 21.37 19.97 | 22.65 4 | 7 Good
    10Y Return % 13.54 8.26 14.20 13.54 | 15.49 4 | 4 Poor
    1Y SIP Return % 7.34 6.91 -11.47 | 15.60 9 | 15 Average
    3Y SIP Return % 15.66 14.31 10.56 | 16.84 4 | 8 Good
    5Y SIP Return % 18.55 16.90 15.24 | 19.28 2 | 8 Very Good
    7Y SIP Return % 20.99 19.95 18.62 | 21.66 2 | 7 Very Good
    10Y SIP Return % 18.06 17.59 17.33 | 18.06 1 | 4 Very Good
    Standard Deviation 14.75 15.97 14.75 | 16.83 1 | 8 Very Good
    Semi Deviation 10.70 11.32 10.52 | 12.07 2 | 8 Very Good
    Max Drawdown % -12.33 -14.79 -16.36 | -12.33 1 | 8 Very Good
    VaR 1 Y % -15.67 -19.09 -23.30 | -15.67 1 | 8 Very Good
    Average Drawdown % -5.39 -5.48 -6.79 | -3.72 4 | 8 Good
    Sharpe Ratio 1.20 1.01 0.85 | 1.20 1 | 8 Very Good
    Sterling Ratio 1.09 0.92 0.79 | 1.09 1 | 8 Very Good
    Sortino Ratio 0.63 0.53 0.43 | 0.63 1 | 8 Very Good
    Jensen Alpha % 4.20 0.91 -2.04 | 4.20 1 | 8 Very Good
    Treynor Ratio -0.46 -0.43 -0.48 | -0.40 7 | 8 Poor
    Modigliani Square Measure % 27.07 23.67 20.89 | 27.07 1 | 8 Very Good
    Alpha % -1.04 -1.43 -3.34 | 1.08 3 | 8 Good
    Return data last Updated On : April 30, 2026.
    Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : March 30, 2026
    KPIs: Key Performance Indicators

    Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


    Date Sbi Healthcare Opportunities Fund NAV Regular Growth Sbi Healthcare Opportunities Fund NAV Direct Growth
    30-04-2026 439.2578 507.0144
    29-04-2026 438.2683 505.8588
    28-04-2026 436.9115 504.2791
    27-04-2026 438.098 505.6352
    24-04-2026 426.364 492.0527
    23-04-2026 432.924 499.61
    22-04-2026 431.777 498.2731
    21-04-2026 430.4301 496.7055
    20-04-2026 430.1499 496.3688
    16-04-2026 427.8197 493.6271
    15-04-2026 427.5636 493.3184
    13-04-2026 422.1891 487.0913
    10-04-2026 423.3343 488.3734
    09-04-2026 419.649 484.109
    08-04-2026 417.0928 481.1472
    07-04-2026 411.0762 474.194
    06-04-2026 410.3872 473.3857
    02-04-2026 409.0548 471.7953
    01-04-2026 415.1404 478.8006
    30-03-2026 415.5149 479.2058

    Fund Launch Date: 01/Jan/1993
    Fund Category: Pharma Fund
    Investment Objective: To provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
    Fund Description: An open-ended Equity Scheme investing in healthcare sector
    Fund Benchmark: S&P BSE HEALTHCARE Index
    Source: Fund FactSheet

    Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.